U.S.-listed shares of Abivax climbed more than 25% in after-hours trading after the French biotech released new data aimed at ...

Abivax Reports Positive ABTECT Maintenance Part 2 Results for Obefazimod, Demonstrating Meaningful Clinical Benefit in Refractory Ulcerative ...

AbivaxABVX stock crashed by more than a third Tuesday despite what one analyst called "best-case" results for a study of its ulcerative colitis treatment after several patients developed cancer. At ...

Ulcerative Colitis Market grows at 5.4% CAGR (2025–2033), reaching US$ 12.79 Billion on rising biologic adoption, biosimilars, and personalized IBD therapies. North America leads the ulcerative ...

Hyperbaric oxygen therapy was well tolerated in treatment-refractory ulcerative colitis and enhanced clinical outcomes alongside improved bowel perfusion.

Ulcerative colitis (UC) is a chronic idiopathic inflammatory disease affecting the gastrointestinal tract. Although paeonol has been used for treating UC due to its anti-inflammatory and antioxidant ...

Ulcerative colitis (UC) is a chronic disease characterized by intestinal inflammation, mucosal damage, and immune dysregulation. Current treatments are often inadequate, driving the search for ...

You’ve followed your ulcerative colitis (UC) treatment plan to a T, and yet you’re still experiencing symptoms that won’t let up — or even seem to be taking a turn for the worse. There’s an ...

Amebic Colitis is caused by the anaerobic parasitic amoebozoan Entameba histolytica. This bacterium infects the mucosa in the colon and accounts for 100,000 deaths annually. The parasite infects 10% ...